Business
Annual Financial Report
Annual Financial Report.
About this update from Nuformix Plc
[{"type":"text","content":"\n \nRNS Number : 5388H Nuformix PLC 01 August 2019 \n\n \nNuformix Plc\n(\"Nuformix\" or the \"Company\")\n \n2019 Annual Financial Report and Notice of Annual General Meeting\n \nCambridge, UK, 1 August 2019: Nuformix (LSE: NFX), the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs, is pleased to announce that the following documents have been posted to its shareholders:\n \n· Annual Financial Report 2019\n· 2019 Notice of Annual General Meeting\n \nA full pdf version of the Annual Financial Report 2019 together with the Notice of Annual General Meeting will be available for download from the Investor Information section on the Company's website www.nuformix.com.\n \nCopies of the Annual Financial Report 2019 and the Notice of 2019 Annual General Meeting will be submitted to the National Storage Mechanism shortly and be available for inspection at http://www.morningstar.co.uk/uk/NSM. The Nuformix Annual Financial Report will be filed with the Registrar of Companies in due course and copies can be obtained from the Company Secretary, SGH Company Secretaries Limited, 60 Gracechurch Street, London, EC3V 0HR.\n \nThe Annual General Meeting will be held on Tuesday 10 September 2019 at 1.00 pm at the offices of Shakespeare Martineau, 6th floor, 60 Gracechurch Street, London, EC3V 0HR.\n \nMarket Abuse Regulation (MAR) Disclosure. Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the publication of this announcement via a Regulatory Information Service and accordingly, this inside information is now considered to be in the public domain.\n \nEnquiries:\n \n\n\n\nNuformix plc\nDr Dan Gooding, Chief Executive Officer\n\n\n+44 (0)1223 627222\n \n\n\n\n\nOptimum Strategic Communications\nMary Clark, Supriya Mathur\nEmail: [email protected]\n\n\n +44 (0) 203 950 9144\n \n\n\n\n \nAbout Nuformix plc www.nuformix.com \nNuformix is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs. Nuformix...